Akshanth Polepally

Company: Abbvie

Job title: Research Fellow & Director, Clinical Pharmacology

Seminars:

Optimizing Strategic Dose Selection in First-in-Human Trials Using MIDD: Enhancing Patient Safety & Accelerating Drug Development 9:00 am

How model-based predictions can guide safer, more effective dose selection Understand the key challenges that arise in FIH trials and how modelling can mitigate them Hear examples of FIH oncology trials accelerated through smarter starting dose strategies and how these have saved costsRead more

day: Day 1